About Us
VENOVATE is an innovative, European-funded initiative dedicated to unlocking the vast biotechnological and therapeutic potential of animal venoms. While venoms have already delivered life-saving drugs to the market, they remain a largely untapped resource for modern medicine.
Funded by a COST Innovators Grant (European Cooperation in Science and Technology), VENOVATE addresses critical bottlenecks in venom-based drug discovery. It aims to bridge the gap between academic research and industrial commercialization through:
